Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Mucositis associated with stem cell transplantation: current status and innovative approaches to management

Bone Marrow Transplantation volume 27, pages S3–S11 (2001)Cite this article

Abstract

Treatment-related morbidity, and in some cases, mortality, associated with autologous and allogeneic bone marrow transplantation has decreased in the past decade largely due to the use of blood stem cells combined with hematopoietic growth factors. However, these procedures remain morbid, with several series documenting regimen-related injury to the oral mucous membranes, the worst form of toxicity from a patient perspective. The pathophysiology of transplant-related mucositis is related to two major events: direct mucosal basal cell injury leading to atrophy and ulcerations, and local infections that can become systemic, the latter of which are exacerbated by the severe neutropenia accompanying high-dose chemotherapy. Recent investigational agents designed to interfere with these two aspects of mucositis have been developed and are showing promise in early clinical trials. In particular, keratinocyte growth factor (KGF) and interleukin-11 appear active. They increase basal cell proliferation, prevent apoptosis due to the preparative regimen, and appear to ameliorate the mucositis seen with high-dose chemotherapy regimens. Oral, nonabsorbable anti-infective agents are also being tested in an attempt to prevent both local and systemic infections. Devoid of significant side-effects, KGF is now in large phase 2 trials that, if positive, will be a significant advance in promoting less morbid transplants by reducing pain and the risk of secondary infections and thus may reduce supportive care costs. Bone Marrow Transplantation (2001) 27, Suppl. 2, S3–S11.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Get just this article for as long as you need it

$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

References

  1. Sonis S, Clark J . Prevention and management of oral mucositis induced by antineoplastic therapy Oncology 1991 5: 11–18

    CAS  PubMed  Google Scholar 

  2. Woo SB, Sonis ST, Monopoli MM et al. A longitudinal study of oral ulcerative mucositis in bone marrow transplant recipients Cancer 1993 72: 1612–1617

    Article  CAS  Google Scholar 

  3. McGuire DB, Altomonte V, Peterson DE et al. Patterns of mucositis and pain in patients receiving preparative chemotherapy and bone marrow transplantation Oncol Nurs Forum 1993 20: 1493–1502

    CAS  PubMed  Google Scholar 

  4. Pico JL, Avila-Garavito A, Naccachie P . Mucositis: its occurrence, consequences, and treatment in the oncology setting The Oncologist 1998 3: 446–451

    CAS  PubMed  Google Scholar 

  5. Bearman SI, Appelbaum FR, Buckner CD et al. Regimen-related toxicity in patients undergoing bone marrow transplantation J Clin Oncol 1988 6: 1562–1568

    Article  CAS  Google Scholar 

  6. Bellm LA, Epstein JB, Rose-Ped A et al. Patient reports of complications of bone marrow transplantation Supp Care Cancer 2000 8: 33–39

    CAS  Google Scholar 

  7. Peterson DE . Research advances in oral mucositis Curr Opin Oncol 1999 11: 261–266

    Article  CAS  Google Scholar 

  8. Sonis ST . Mucositis as a biological process: a new hypothesis for the development of chemotherapy-induced stomatotoxicity Oral Oncol 1998 34: 39–43

    Article  CAS  Google Scholar 

  9. Wilkes JD . Prevention and treatment of oral mucositis following cancer chemotherapy Semin Oncol 1998 25: 538–551

    CAS  PubMed  Google Scholar 

  10. Classen DC, Burke JP, Ford CD et al. Streptococcus mitis sepsis in bone marrow transplant patients receiving oral antimicrobial prophylaxis Am J Med 1990 89: 441–446

    Article  CAS  Google Scholar 

  11. Gamis AS, Howells WB, De Swarte-Wallace J et al. Alpha hemolytic streptococcal infection during intensive treatment for acute myeloid leukemia: a report from the Children's Cancer Group Study CCG-2891 J Clin Oncol 2000 18: 1845–1855

    Article  CAS  Google Scholar 

  12. Richard P, Amador Del Valle G, Moreau P et al. Viridans streptococcal bacteraemia in patients with neutropenia Lancet 1995 345: 1607–1609

    Article  CAS  Google Scholar 

  13. Heimdahal A, Mattson T, Dahlof G et al. The oral cavity as a port for early infection in patients treated with bone marrow transplantation Oral Surg Oral Med Oral Pathol 1989 68: 711–716

    Article  Google Scholar 

  14. Steiner M, Villablanca J, Kersey J et al. Alpha streptococcal shock in bone marrow transplantation patients Blood 1988 72: 409a (Abstr.)

    Google Scholar 

  15. Greenspan D . Xerostomia: diagnosis and management Oncology 1996 10: 7–11

    CAS  PubMed  Google Scholar 

  16. Parulekar W, Mackenzie R, Bjarnason G et al. Scoring oral mucositis Oral Oncol 1998 34: 63–71

    Article  CAS  Google Scholar 

  17. Squier CA . Oral complications of cancer therapies. Mucosal alterations NCI Monogr 1990 9: 169–172

    Google Scholar 

  18. Schubert MM . Measurement of oral tissue damage and mucositis pain. In: Chapman OR, Foley KH (eds) Current and Emerging Issues in Cancer Pain: Research and Practice Row Press: New York 1993 247–265

    Google Scholar 

  19. World Health Organization . Handbook for Reporting Results of Cancer Treatment Geneva: World Health Organization 1979 pp 15–22

  20. Sonis ST, Eilers JP, Epstein JB et al. Validation of a new scoring system for the assessment of clinical trial research of oral mucositis induced by radiation or chemotherapy. Mucositis Study Group Cancer 1999 85: 2103–2113

    Article  CAS  Google Scholar 

  21. Western Consortium for Cancer Nursing Research . Development of a staging system for chemotherapy-induced stomatitis Cancer Nurs 1991 14: 6–12

    Google Scholar 

  22. Western Consortium for Cancer Nursing Research . Assessing stomatitis: Refinement of the Western Consortium for Cancer Nursing Research (WCCNR) stomatitis staging system Can Oncol Nurs J 1998 8: 160–165

    Article  Google Scholar 

  23. Eilers J, Berger AM, Petersen MC . Development, testing, and application of the oral assessment guide Oncol Nurs Forum 1988 15: 325–330

    CAS  PubMed  Google Scholar 

  24. Rapoport AP, Watelet LF, Linder T et al. Analysis of factors that correlate with mucositis in recipients of autologous and allogeneic stem cell transplants J Clin Oncol 1999 17: 2446–2453

    Article  CAS  Google Scholar 

  25. Horowitz MM, Oster G, Fuchs H et al. Oral Mucositis Assessment Scale (OMAS) as a predictor of clinical and economic outcomes in bone marrow transplant patients Blood 1999 94 (Suppl. 1): 399a (Abstr.)

    Google Scholar 

  26. Ruescher TJ, Sodeifi A, Scrivani SJ et al. The impact of mucositis on alpha hemolytic streptococcal infection in patients undergoing autologous bone marrow transplantation for hemotologic malignancies Cancer 1998 82: 2275–2281

    Article  CAS  Google Scholar 

  27. Villablanca JG, Steiner M, Kersey J et al. The clinical spectrum of infections with viridans streptococci in bone marrow transplant patients Bone Marrow Transplant 1990 5: 387–393

    CAS  PubMed  Google Scholar 

  28. Pico J, Chan W, Durrant S et al. The relationship between mucositis, quality of life, and clinical sequelae in lymphoma patients receiving high dose chemotherapy with autologous PBPC transplantation Blood 1999 94 (Suppl. 1): 128b (Abstr.)

    Google Scholar 

  29. Borowski B, Benhamou E, Pico JL et al. Prevention of oral mucositis in patients treated with high-dose chemotherapy and bone marrow transplantation: a randomised controlled trial comparing two protocols of dental care Eur J Cancer B Oral Oncol 1994 30B: 93–97

    Article  CAS  Google Scholar 

  30. O'Dwyer ST, Scott T, Smith RJ, Wilmore DW . 5-Fluorocuacil toxicity on small intestine but not white blood cells is decreased by glutamine Clin Res 1987 35: 367a (Abstr.)

    Google Scholar 

  31. Fox AD, Kripke SA, De Paula J et al. Effect of a glutamine supplemented enteral diet on methotrexate-induced enterocolitis J Parenter Enteral Nutr 1988 12: 325–331

    Article  CAS  Google Scholar 

  32. Anderson PM, Schroeder G, Skubitz KM . Oral glutamine reduces the duration and severity of stomatitis after cytotoxic cancer chemotherapy Cancer 1998 83: 1433–1439

    Article  CAS  Google Scholar 

  33. Schloerb PR, Skikne BS . Oral and parenteral glutamine in bone marrow transplantation: a randomized, double-blind study J Parenter Enteral Nutr 1999 23: 117–122

    Article  CAS  Google Scholar 

  34. MacBurney M, Young LS, Ziegler TR et al. A cost-evaluation of glutamine supplemented parenteral nutrition in adult bone marrow transplant patients J Am Diet Assoc 1994 94: 1263–1266

    Article  CAS  Google Scholar 

  35. Anderson PM, Ramsay NK, Shu XO et al. Effect of low-dose oral glutamine on painful stomatitis due to bone marrow transplantation Bone Marrow Transplant 1998 22: 339–344

    Article  CAS  Google Scholar 

  36. Johnston EM, Crawford J . Hematopoietic growth factors in the reduction of chemotherapeutic toxicity Semin Oncol 1998 25: 552–561

    CAS  PubMed  Google Scholar 

  37. Crawford J, Glaspy J, Vincent M et al. Effect of filgrastim (r-methu G-CSF) on oral mucositis in patients with small cell lung cancer (SCLC) receiving chemotherapy (cyclophosphamide, doxorubicin, and etoposide, CAE) Proc Am Soc Clin Oncol 1994 13: 442 (Abstr.)

    Google Scholar 

  38. Gabrilove JL, Jakubowski A, Scher H et al. Effect of granulocyte colony stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium New Engl J Med 1988 318: 1414–1422

    Article  CAS  Google Scholar 

  39. Rosso M, Blasi G, Gherlone E et al. Effect of granulocyte–macrophage colony-stimulating factor on prevention of mucositis in head and neck cancer patients treated with chemo-radiotherapy J Chemother 1997 9: 382–385

    Article  CAS  Google Scholar 

  40. Nemunaitis J, Rosenfeld CS, Ash R et al. Phase III randomized, double-blind placebo-controlled trial of rhGM-CSF following allogeneic bone marrow transplantation Bone Marrow Transplant 1995 15: 949–954

    CAS  PubMed  Google Scholar 

  41. Atkinson K, Biggs JC, Downs K et al. GM-CSF after allogeneic bone marrow transplantation: accelerated recovery of neutrophils, monocytes and lymphocytes Aust NZ J Med 1991 21: 686–692

    Article  CAS  Google Scholar 

  42. Karthaus M, Rosenthal C, Huebner G et al. Effect of topical oral G-CSF on oral mucositis: a randomised placebo-controlled trial Bone Marrow Transplant 1998 22: 781–785

    Article  CAS  Google Scholar 

  43. Wardley AM, Scarffe JH . Role of granulocyte–macrophage colony-stimulating factor in chemotherapy-induced oral mucositis J Clin Oncol 1996 14: 1741–1743

    Article  CAS  Google Scholar 

  44. Ovilla-Martinez R, Rubio ME, Borbolla JR, Gonzalez JE . GM-CSF mouth washes as treatment for oral mucositis after intensive chemotherapy with or without bone marrow transplantation Blood 1994 84 (Suppl. 1): 717a (Abstr.)

    Google Scholar 

  45. Robson M, Kucukcelebi A, Carp SS et al. Effects of granulocyte–macrophage colony-stimulating factor on wound contraction Eur J Clin Microbiol Infect Dis 1994 13: S41–S46

    Article  Google Scholar 

  46. Du XX, Williams DA . Interleukin-11: a multifunctional growth factor derived from the hematopoietic microenvironment Blood 1994 83: 2023–2030

    CAS  PubMed  Google Scholar 

  47. Potten CS . Protection of the small intestinal clonogenic stem cells from radiation-induced damage by pre-treatment with interleukin 11 also increases murine survival time Stem Cells 1996 14: 452–459

    Article  CAS  Google Scholar 

  48. Orazi A, Du X, Yang Z et al. Interleukin-11 prevents apoptosis and accelerates recovery of small intestinal mucosa in mice treated with combined chemotherapy and radiation Lab Invest 1996 75: 33–42

    CAS  PubMed  Google Scholar 

  49. Hill GR, Cooke KR, Teshima T et al. Interleukin-11 promotes T cell polarization and prevents acute graft-versus-host disease after allogeneic bone marrow transplantation J Clin Invest 1998 102: 115–123

    Article  CAS  Google Scholar 

  50. Hill GR, Ferrara JL . The primacy of the gastrointestinal tract as a target organ of acute graft-vs-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation Blood 2000 95: 2754–2759

    CAS  Google Scholar 

  51. Schwerkoske J, Schwartzberg L, Weaver C et al. A phase I, double-masked, placebo-controlled study to evaluate tolerability of Neumega (rh IL-11; opreleukin) to reduce mucositis in patients with solid tumors or lymphoma receiving high dose chemotherapy with autologous peripheral blood stem cell reinfusion Proc Am Soc Clin Oncol 1999 18: 584a (Abstr.)

    Google Scholar 

  52. De Walt EM, Haines AK . The effects of specified stressors on healthy oral mucosa Nurs Res 1969 18: 22–27

    Article  CAS  Google Scholar 

  53. Samaranayake LP, Robertson AG, MacFarlane TW et al. The effect of chlorhexidine and benzydamine mouthwashes on mucositis induced by therapeutic irradiation Clin Radiol 1988 39: 291–294

    Article  CAS  Google Scholar 

  54. Vesole DH, Fuchs HJ, IB-367 Phase II Investigators . IB-367 reduces the number of days of severe oral mucositis complicating myeloablative chemotherapy Blood 1999 94 (Suppl. 1): 154a (Abstr.)

    Google Scholar 

  55. Rubin JS, Osada H, Finch PW et al. Purification and characterization of a newly identified growth factor specific for epithelial cells Proc Natl Acad Sci USA 1989 86: 802–806

    Article  CAS  Google Scholar 

  56. Finch PW, Rubin JS, Miki T et al. Human KGF is FGF-related with properties of a paracrine effector of epithelial cell growth Science 1989 245: 752–755

    Article  CAS  Google Scholar 

  57. Khan WB, Shui C, Ning S et al. Enhancement of murine intestinal stem cell survival after irradiation by keratinocyte growth factor Radiat Res 1997 148: 248–253

    Article  CAS  Google Scholar 

  58. Farrell CL, Bready JV, Rex KL et al. Keratinocyte growth factor protects mice from chemotherapy and radiation-induced gastrointestinal injury and mortality Cancer Res 1998 58: 933–939

    CAS  PubMed  Google Scholar 

  59. Danilenko DM . Preclinical and early clinical development of keratinocyte growth factor, an epithelial-specific growth factor Toxicol Pathol 1999 27: 64–71

    Article  CAS  Google Scholar 

  60. Playford RJ, Marchbank T, Mandir N et al. Effects of keratinocyte growth factor (KGF) on gut growth and repair J Pathol 1998 184: 316–322

    Article  CAS  Google Scholar 

  61. Farrell CL, Rex KL, Kaufman SA et al. Effects of keratinocyte growth factor in the squamous epithelium of the upper aerodigestive tract of normal and irradiated mice Int J Radiat Biol 1999 75: 609–620

    Article  CAS  Google Scholar 

  62. Ulich TR, Whitcomb L, Tang W et al. Keratinocyte growth factor ameliorates cyclophosphamide-induced ulcerative hemorrhagic cystitis Cancer Res 1997 57: 472–475

    CAS  PubMed  Google Scholar 

  63. Krijanovski OI, Hill GR, Cooke KR et al. Keratinocyte growth factor separates graft-versus-leukemia effects from graft-versus-host disease Blood 1999 94: 825–831

    CAS  PubMed  Google Scholar 

  64. Durrant S, Pico JL, Schultz N et al. A phase I study of recombinant keratinocyte growth factor (rHuKGF) in lymphoma patients receiving high-dose chemotherapy with autologous peripheral blood progenitor cell transplantation Blood 1999 94 (Suppl. 1): 708a (Abstr.)

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Loyola University Medical Center, Maywood, IL, USA

    P Stiff

Authors
  1. P Stiff
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Stiff, P. Mucositis associated with stem cell transplantation: current status and innovative approaches to management. Bone Marrow Transplant 27 (Suppl 2), S3–S11 (2001). https://doi.org/10.1038/sj.bmt.1702863

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1702863

Keywords

  • high-dose chemotherapy
  • mucositis
  • stem cell transplantation

This article is cited by

Search

Advanced search

Quick links